bioAffinity Technologies (BIAF) EBT (2022 - 2025)
Historic EBT for bioAffinity Technologies (BIAF) over the last 4 years, with Q3 2025 value amounting to -$5.0 million.
- bioAffinity Technologies' EBT fell 15261.22% to -$5.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$14.7 million, marking a year-over-year decrease of 7431.28%. This contributed to the annual value of -$9.0 million for FY2024, which is 1404.95% down from last year.
- According to the latest figures from Q3 2025, bioAffinity Technologies' EBT is -$5.0 million, which was down 15261.22% from -$4.0 million recorded in Q2 2025.
- In the past 5 years, bioAffinity Technologies' EBT ranged from a high of -$88052.0 in Q2 2022 and a low of -$5.0 million during Q3 2025
- Moreover, its 4-year median value for EBT was -$2.1 million (2024), whereas its average is -$2.5 million.
- The largest annual percentage gain for bioAffinity Technologies' EBT in the last 5 years was 5347.6% (2023), contrasted with its biggest fall of 187109.21% (2023).
- Over the past 4 years, bioAffinity Technologies' EBT (Quarter) stood at -$1.7 million in 2022, then crashed by 41.58% to -$2.4 million in 2023, then dropped by 25.14% to -$3.0 million in 2024, then tumbled by 70.14% to -$5.0 million in 2025.
- Its EBT was -$5.0 million in Q3 2025, compared to -$4.0 million in Q2 2025 and -$2.7 million in Q1 2025.